TITLE

Structure elucidation and HPLC-MS/MS determination of a potential biomarker for estradiol administration in cattle

AUTHOR(S)
Regal, Patricia; Seijas, Julio A.; Cepeda, Alberto; Fente, Cristina
PUB. DATE
November 2013
SOURCE
Analytical & Bioanalytical Chemistry;Nov2013, Vol. 405 Issue 27, p9537
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Administration of hormonal compounds as growth promoters in livestock farming was banned by Council Directive 96/22/EC. However, this kind of substances is sometimes reported within the framework of European monitoring residue plans. Various analytical methods have been previously developed to screen for their misuse, and they are now especially efficient for monitoring the illegal administration of synthetic and semisynthetic hormones. Nevertheless, proving an exogenous administration of hormones from natural origin (i.e., estradiol-17β or progesterone) still remains a challenge for European authorities. These target compounds are indeed always present in the animal matrix, and the establishment of reference thresholds appears very difficult because of the extreme variability existing among animals. In 2011, a metabolomics study was performed on serum samples obtained from cows treated with estradiol-17β (or its ester estradiol benzoate) and from control animals using a high-performance liquid chromatography (HPLC)-LTQ-Orbitrap system. After appropriate data processing and multivariate statistical analysis (orthogonal partial least squares discriminant analysis), it was possible to highlight one potential biomarker candidate of estradiol treatments in bovine animals. Now, this biomarker has been structurally elucidated as a dipeptide, and its usefulness has been tested through a targeted HPLC-MS/MS method. Its presence in the previous samples has been confirmed and also in additional samples from estradiol-treated animals.
ACCESSION #
91930368

 

Related Articles

  • Effects of supplementary bee pollen and its polysaccharides on nutrient digestibility and serum biochemical parameters in Holstein calves. Yan Tu; Guo-Feng Zhang; Kai-Dong Deng; Nai-Feng Zhang; Qi-Yu Diao // Animal Production Science;2015, Vol. 55 Issue 10, p1318 

    This study investigated the effects of supplementing the diets of 14-70-day calves with dietary bee pollen (BP) or its polysaccharides (PS) on growth performance, serum biochemical parameters, and apparent nutrient digestibility. Twenty-five newborn Holstein female calves were randomly offered...

  • Estrogen replacement therapy.  // Geriatrics;June97, Vol. 52 Issue 6, p21 

    Discusses the estradiol transdermal system (Alora) approved by the food and Drug Administration on the treatment of vasomotor symptoms associated with menopause. Packaging of the drug; Application of the patch.

  • Estradiol.  // Reactions Weekly;9/25/2010, Issue 1320, p21 

    The article describes the case of a transsexual male who developed meningioma and seizures after receiving sex treatment with estradiol patches.

  • HORMONE REPLACEMENT THERAPIES.  // Monthly Prescribing Reference;Jul2013, Vol. 29 Issue 7, p202 

    A table is presented which provides information on drugs used for hormone replacement therapies including Estradiol, Norethindrone acetate and Medroxyprogesterone acetate (MPA).

  • Prolonged endometrial stimulation associated with oestradiol implants. Gangar, Kevin F.; Fraser, David; Whitehead, Malcolm I.; Cust, Michael P. // BMJ: British Medical Journal (International Edition);2/17/90, Vol. 300 Issue 6722, p436 

    Provides information on endometrial stimulation after discontinuation of treatment with oestradiol implants. Stimulatory effects of implantation; Duration of the stimulation; Avoidance of hyperplasia and carcinoma.

  • Neuroprotection by Estradiol: Some Important Considerations. Barreto, George E. // Human & Experimental Toxicology;Oct2011, Vol. 30 Issue 10, p1737 

    A letter to the editor is presented in response to the article "Protective potential of 17(beta)-estradiol against co-exposure of 4-hydroxynonenal and 6-hydroxydopamine in PC12 cells," by M. A. Siddiqui and colleagues in the 2010 issue.

  • Bisacodyl/estradiol.  // Reactions Weekly;10/27/2012, Issue 1425, p10 

    The article describes the case of a 54-year-old woman scheduled to undergo orthopaedic surgery who experienced acute ischaemic colitis during treatment with bisacodyl for chronic constipation and hormone replacement therapy with estradiol.

  • Estradiol.  // Reactions Weekly;12/11/2010, Issue 1331, p16 

    The article describes the case of a 48-year-old woman who developed areolar hyperpigmentation following transdermal administration of estradiol.

  • Ethinylestradiol/drospirenone.  // Reactions Weekly;5/15/2010, Issue 1301, p23 

    The article describes the case of a 36-year-old woman who acquired upper extremity deep vein thrombosis while undergoing treatment with ethinylestradiol/drospirenone.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics